Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.77M Buy
100,522
+57,084
+131% +$3.8M 0.09% 248
2026
Q1
$2.73M Buy
43,438
+21,108
+95% +$1.47M 0.05% 617
2025
Q4
$1.48M Sell
22,330
-32,803
-59% -$2.12M 0.04% 751
2025
Q3
$3.71M Buy
55,133
+44,555
+421% +$3.53M 0.19% 68
2025
Q2
$923K Sell
10,578
-10,574
-50% -$829K 0.04% 714
2025
Q1
$1.44M Buy
21,152
+11,136
+111% +$909K 0.07% 374
2024
Q4
$779K Sell
10,016
-19,088
-66% -$1.41M 0.06% 444
2024
Q3
$1.95M Buy
+29,104
New +$2.39M 0.14% 154
2024
Q2
Sell
-4,453
Closed -$618K 2006
2024
Q1
$618K Buy
+4,453
New +$560K 0.08% 361
2023
Q4
Sell
-6,447
Closed -$602K 1712
2023
Q3
$602K Buy
6,447
+1,864
+41% +$210K 0.1% 293
2023
Q2
$589K Sell
4,583
-1,544
-25% -$187K 0.11% 277
2023
Q1
$712K Sell
6,127
-2,788
-31% -$312K 0.15% 129
2022
Q4
$1.01M Sell
8,915
-3,397
-28% -$373K 0.21% 84
2022
Q3
$992K Buy
12,312
+4,948
+67% +$419K 0.25% 51
2022
Q2
$549K Sell
7,364
-1,248
-14% -$114K 0.22% 99
2022
Q1
$1.1M Buy
8,612
+6,896
+402% +$754K 0.48% 27
2021
Q4
$230K Buy
+1,716
New +$247K 0.13% 308
2021
Q2
Sell
-7,960
Closed -$715K 868
2021
Q1
$715K Buy
+7,960
New +$747K 0.35% 32

Other funds holding DXCM

XTX Topco's DXCM Position: Q2 2026 in Review

XTX Topco increased its DexCom (DXCM) stake by 131% in Q2 2026, buying an estimated $3.8M and bringing the position to 100,522 shares worth $6.77M. The position accounts for 0.09% of the portfolio, ranked #248.

XTX Topco first reported a position in DXCM in Q1 2021 and has held it in 18 quarters since. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • XTX Topco held 100,522 shares of DexCom worth $6.77M as of Q2 2026.
  • XTX Topco bought 57,084 DexCom shares in Q2 2026, an estimated $3.8M.
  • DexCom made up 0.09% of XTX Topco's portfolio in Q2 2026, its #248 holding.
  • XTX Topco first reported a position in DexCom in Q1 2021 and has held it in 18 quarters since.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.